This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.We hypothesis that long-term, physiologic GH administration to GH deficient patients with HIV lipodystrophy, defined based on responses to standardized stimulation testing, will improve, insulin sensitivity, cardiovascular risk parameters, bone density and body composition.In a randomized, double-blinded, placebo-controlled study, we will determine:A)The effects of long-term physiologic GH dosing on body composition, bone density and markers of bone turnover, CV risk markers including traditional lipid levels and novel inflammatory marker of increased CV risk, and glucose homeostasis;B)Whether the effects of physiologic GH treatment are sustained after GH withdrawal.
Showing the most recent 10 out of 945 publications
